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Background: Tuberculosis (TB) is a major public health problem in Africa with Ethiopia being the most affected.
Treatment delay is an important indicator of access to TB diagnosis and treatment. However, little is known about
factors associated with treatment delay of pulmonary TB among pastoralists. Health facility based cross sectional
study was conducted on 129 pulmonary TB patients in pastoralist community. The study was conducted in three
health centers and a hospital. Time between onset of TB symptoms and first visit to a professional health care
provider (patient delay), and the time between first visits to the professional health care provider to the date of
diagnosis (provider's delay) were analyzed using SPSS 16.0 statistical software.
Findings: A total of 129 new smear positive pulmonary TB patients participated in the study. The median total
delay was 97 days. The median patient and health provider delays were 63 and 34 days, respectively. Ninety six
percent of the patients were delayed for more than the twenty one days cutoff point. Patient delay was positively
associated with first visit to traditional healer/private clinic/drug shop, rural residence, being illiterate, living in more
than 10 kilometers from health facility; severity of illness at first presentation to health facility. Provider delay was
positively associated with rural residence, being illiterate, patient with good functional status, patients in contact
with more than two health providers, and place of first visit being traditional healer/private clinic/drug shop.
Conclusions: This study showed that majority of smear positive patients delayed either for diagnosis or treatment,
thus continue to serve as reservoirs of infection. This indicates that there is a need for intervention to decrease
patient and provider delays. Effort to reduce delays in pastoralist communities should focus on improving access to
services in rural communities, engaging traditional and private health providers and should target illiterate
individuals.
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Background
The STOP Tuberculosis (TB) strategy was introduced in
2006 to achieve the TB related Millennium Development
Goals (MDG) by 2015. The STOP TB strategy focus on ex-
pansion and enhancement of quality DOTS program,
addressing TB/HIV co-infection and MDR TB, health sys-
tem strengthening, involving all providers including the pri-
vate sector, empowering of TB patients and communities,* Correspondence: h_awol@yahoo.com; kebededeka@yahoo.com
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provided the original work is properly cited.and promote and enhance research [1]. Despite all these
efforts, TB is still the major cause of morbidity and mortal-
ity. The 2010 WHO report revealed that there were a total
of 9.4 million incident and 14 million prevalent cases of TB
and 1.3 million deaths in 2009 [2].
To decrease the impact of TB, the United Nations
included TB prevention and control among its eight
Millennium Development Goals, with a proposal to re-
duce TB incidence to half the 1990’ level by 2015. To
measure and achieve this, the World Health Assembly
(WHA) highlighted two indicators: 70% global and in-
country case detection rates and successful treatment of
85% of cases [3]. However, despite this increased effort
invested in TB control, the epidemic rages on. Morerticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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developing world; here 75% of cases are in the most eco-
nomically productive age group (15-54years). An adult
with TB loses on average three to four months of work
time. This results in the loss of 20-30% of annual house-
hold income and, if the patient dies of TB, an average of
15 years of lost income [4].
TB is a major public health problem in the Horn of
Africa with Ethiopia being the most affected where TB
cases increase at the rate of 2.6% each year [5]. The
World Health Organization (WHO) has classified Ethi-
opia 7th among the 22 high burden countries with TB
infection in the world [6,7]. According to the WHO esti-
mate, there incidence and prevalence of all forms of TB
were 572 and 359 per 100,000 respectively. The case de-
tection rate of all forms of TB and smear positive TB
were 50% and 34% respectively [2]. An estimated 5000
MDR TB exists in Ethiopia and only 88 of them had
received second-line anti-TB drugs [2,8]. However, a re-
cent community based national survey indicated a lower
prevalence of TB [9].
In Ethiopia the case detection rate for smear positive
TB is only 34%. This indicates that the proportion of no-
tified cases diagnosed as smear-positive is low in Ethi-
opia, and has stayed within the range 27–36% during the
period 1995–2004, detecting them early and putting
them on treatment and ensuring cure should be the
highest priority [10,11]. Strategies aiming to reduce the
time between the onset of symptoms and the initiation
of effective chemotherapy may impact the infectious
duration in the community and thereby reduce the num-
ber of new infections. However, factors contributing to
treatment delay are potentially numerous, and likely to
vary considerably in relative importance between popu-
lations in their local settings [8].
In Ethiopia many studies have documented delayed
diagnosis and treatment of TB in agrarian communities;
patient delay in Amhara region of Ethiopia (median, 30
days) [12], Awasa, Ethiopia (median, 31 days) [13], and
Tigray region (median, 30 days) [6], in the study con-
ducted among pastoralists of Somali region of Ethiopia
the median delay was found to be 60 days [14]. Whereas
the provider delays in Afar [15], Ethiopia (median, 6
days), Somali, Ethiopia (median, 6 days) [14] and Am-
hara region (median, 21 days) [12].
In the absence of strong information that state factors
contributing to treatment delay of TB among pastoralists
the importance of this study is immense. Due to the dif-
ference in lifestyle of pastoralist communities from the
agrarian communities the extent and factors behind
delays could be different. Most of previous studies con-
ducted in Ethiopia focused on agrarian communities; lit-
tle is known about the prevalence and associated factors
of TB diagnosis and treatment delays among pastoralistcommunities. We performed such study to gain informa-
tion on factors influencing delay to TB treatment among
pastoralist in Bale zone in particular and in Ethiopia in
general.
Methods
A cross-sectional survey was conducted from February
to March 2011 in one hospital (Ginner Hospitals) and
three health centers (Reyitu, Sewena and Dallo manna
Health Centers) of the pastoralist community in Bale
Zone. The zone is found in Oromia Region with total
population of 1,593,298 projected in 2011 of these;
601,556 populations are pastoralist and are subdivided
administratively into 19 districts and two city adminis-
tration with a total of 401 Kebeles (lowest government
administrative structure). Of 19 districts 9 districts are
pastoralist where a hospital and 6 health centers serve as
diagnostic and treatment centers for DOTS [16]. The
study populations are all pulmonary positive TB patients
on treatment for less than 15 days and newly diagnosed
pulmonary positive TB patients in the selected hospital
and health centers (Figure 1).
Sampling and sample size
All pulmonary TB patients newly diagnosed during the
study or on treatment for less than 15 days were
included in the study. According to the zonal health de-
partment report of the previous year and three consecu-
tive months before data collection period, it was
expected that 135 pulmonary positive TB patients would
be available during the study period [16].
Selection of the health facilities
There were a hospital and nine health centers in the
area. Of the total health facilities six health center and a
hospital provide both diagnosis and anti-TB treatment.
Of this three health centers were selected randomly and
a hospital selected purposively.
For each selected health facility study subjects were
allocated proportional to their patient flow based on
their previous year TB patient report and three consecu-
tive months before study period. As a result, Ginner
hospital 50 patients, DalloMana health center 32
patients, Rayitu health center 27 patients and Sewena
health center 26 patients.
Data collection and tools
This study used an interviewer administered question-
naire which was adopted from similar studies done in
Ethiopia and elsewhere [12,14,17,18]. Before interview-
ing the patients, eligible study subjects were identified
by reviewing the TB registration. Information such as
name of the DOTS centre, name of the diagnostic centre
for sputum examination, patient's registration number
Figure 1 Map of the study sites, Ethiopia.
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ment started was abstracted from TB unit registers and
TB treatment cards.
There were 6 nurse enumerators and three supervisors
who had BSc degree in Nursing. Individuals who can
speak the local languages Afan Oromo and Amharic
were recruited from respective health facilities from dif-
ferent department. The collected information from the
TB registry and the patients were reported to the super-
visor every 2–3 days, to enable taking immediate action
in case inconsistencies and problems happen on the
reported data. Reports were crosschecked with the main
TB registry found in the respective health facilities. Ef-
fort was made to contact eligible patients who were on
treatment for less than 15 days of TB treatment but not
visiting the health facilities during the study period.
Respondents were first asked to estimate the time in
days they had been experiencing cough or other symp-
tom before presenting to health facilities with the
current diagnosis of TB. A calendar based on local reli-
gious, political and agricultural events was used to col-
lect information on date of onset of first symptoms
suggestive of TB, for patient unable to estimate the date.
The questionnaire has one separate page designed to
extract diagnosis and treatment information from TBregisters (TB treatment cards and unit TB registers).
The questionnaire contained the following questions:
Demographic and socio-economic variables: age, sex, oc-
cupation, education level, and family size; disease factors:
symptoms and their duration, date of first presentation
to a modern health facility, results of sputum micros-
copy for AFB, date diagnosis confirmed, date treatment
commenced, type of the patient (new case, relapse, fail-
ure, transfer in, return after default) and others ; psycho-
logical factors: patient beliefs, perceptions, stigma,
attitudes and knowledge about TB; Institutional or
health service factors: distance to health facilities, costs
of travel, medical expenditure on treatment of TB
related symptoms , reasons for delay. Each interview
schedule was last approximately 40 minutes per study
subjects and allow for careful probing of responses to
minimize recall bias. Other data sources were case notes
and referral letters used.
Data quality control
The following measures were taken to maintain and in-
crease the reliability and validity of the study. The ques-
tionnaire was pre tested on 10%( 14) TB patients who
were not illegible for the study. Based on the pre test
modifications were incorporated to the questionnaire.
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ing in knowing the date for different events by the study
subjects, key events after start of symptom and the date
was asked in different ways to cross check with total
duration the patients reported.
The enumerators and supervisors were trained for two
days about administering the instruments.
Frequent follow up was done during the phase of data
collection. Data was checked and entered at the field
level by the investigator and cleaned before analyses. All
of the entered data was checked again before final
analysis.
Data Analysis
Data were checked for its completeness every day, edi-
ted, coded, entered, cleaned and analyzed using SPSS
version-16. The collected data were processed by using
both descriptive and analytical method which includes
tables, summery measures of central tendency (like
mean and median) and dispersion (standard deviation,
range), odds ratio and confidence intervals were used.
Logistic regression was done for significant variables to
identify factors associated with treatment delay. P-value
< 0.05 was considered statistically significant. Two logis-
tic regression models were produced to indentify factors
associated with patient and provider delays.
Analyses of knowledge about and stigma associated with
TB
Subjects were asked specific questions/statements to as-
sess their knowledge about signs and symptoms and per-
ceived causes of TB, and stigma associated with TB.
Then a separate summary indicator was developed for
analyses by dividing the total score into three strata,
≤25th percentile, between 25th and 75th percentile and
≥75th percentile. Subjects who scored below or equal to
the 25th percentile for knowledge questions were con-
sidered to have “unsatisfactory knowledge”, those who
scored between the 25 and 75 percentile was regarded as
having “average (fair) knowledge”, while those who
scored above or equal to the 75 percentile was consid-
ered to be “knowledgeable” on TB. Similar procedure
was used for stigma level associated with TB. Accord-
ingly, subjects were categorized as “no perceived
stigma,” “some perceived stigma” and “high perceived
stigmata” [18].
Operational definition
In this study the following operational definitions were
used: Patient delay is the time interval from the appear-
ance of the first symptom of TB until the first visit to
health care facility. Thus, patients who consulted health
care facilities more than 2 weeks after the onset of the
constitutional signs and symptoms of TB are consideredas ‘delayed’. Health provider delay: Health provider delay
in this context is defined as the time ranging from
patient’s first contact to any modern health facility to
date of commencement of anti-TB treatment. This com-
prises time spent during referrals between facilities, diag-
nosis and time between diagnosis and start of treatment.
Thus, period between reporting to a health facility and
initiation of treatment for more than 7 days would be
considered as ‘delayed’. Total delay is the sum of patient
delay and health provider delay.
The diagnosis of TB was according to the national TB
diagnosis algorism. A case of TB is a patient in whom
TB has been confirmed by sputum examination or by a
clinician. A pulmonary case is a patient with TB disease
involving the lung. A case of smear positive pulmonary
TB is a patient with at least two initial positive sputum
smears, or one sputum smear positive plus radiographic
abnormalities consistent with active pulmonary TB as
determined by a clinician. A sputum smear negative pul-
monary TB case is a patient diagnosed with pulmonary
TB by a clinician not meeting the above criteria for
smear-positive disease. In the context of the study TB
diagnosis was based on sputum examination, radio-
graphic abnormalities, there were no services of culture
in the area.
Pastoralists are migratory people whose livelihood
largely depends on livestock raising. These people move
seasonally in search of pasture and water.
Ethical consideration
The study protocol was approved by the ethical review
committees of Jimma University, Official letter of co-
operation was also written to Bale Zone Administration.
Letter of co- operation was obtained from Zonal Health
Desk to the four selected health institutions. Informed
written consent was obtained from each study partici-
pants. Privacy and strict confidentiality was assured for
the information provided and their names were not
included in the questionnaire. Referral to counseling and
testing for HIV/AIDS was done for all patients.
Results
Socio-demographic characteristics of the participants
A total of 136 smear positive pulmonary TB patients
were registered. Seven patients were excluded from the
study (5 cases were aged below 15 years and 2 case were
critically ill and unable to respond). A total of 129 pul-
monary TB patients were eligible for this study with
ninety six percent (96%) response rate. Most of the par-
ticipants (56%) were males, 66.7% found in the age
group 15–35 years, 75.2% reside in rural areas, 69.0%
were married, 73.6% were illiterate, Most(75.2%) were
Oromo by ethnicity and 90.7% Muslim by religion and
almost half (49.6%) were pastoralist, by occupation.
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deviation of 14.32. The average monthly family income
was 300.58 Eth. Birr (1USD= 13ETB). Among the study
subjects 89(69%) lived beyond 10 km from a health facil-
ity. (Table 1)Clinical characteristics and health seeking patterns of the
patients
The major signs and symptoms that patients experi-
enced during the onset of their illness were cough for
more than 2 weeks (94.5%), followed by night sweating
(89%), loss of appetite (85.3%), and fever for more than 2
weeks (72.1%), weight loss (69.7%), chest pain (58.1%)
and bloody sputum (30.2%).Table 1 General characteristics of pulmonary Tuberculosis
patients (n = 129) in pastoralist community in Bale Zone,
April 2011
Patient characteristics Frequency Percent
Age (years) 15 – 25 48 37. 2
26 – 35 38 29.5
36 – 45 21 16.3
> 45 22 17.1
Sex Male 73 56.6
Female 56 43.4
Place of residence Rural 97 75.2
Urban 32 24.8




Religion Orthodox Christian 11 8.5
Muslim 117 90.7
Catholic 1 0.8
Ethnicity Oromo 97 75.2
Amara 8 6.2
Somale 24 18.6
Education Illiterate 95 73.6
Read and write 8 6.2
Primary (1–4) 16 12.4
Junior (5–8) 3 2.3
Secondary (9–12) 6 4.7
12+ 1 0.8
Family size 1 to 3 person 11 8.50
4 to 6 person 55 42.60
> 6 persons 63 48.80
Distance from health facility ≤10 Km 37 28.6
>10 Km 92 71.4Concerning first place of contact for seeking help 32%
of patients reported first to Drug shop/pharmacy or pri-
vate health facility. Significant (30%) patients reported to
traditional healers before they visited any other conven-
tional health facilities. The first place of contact for seek-
ing help was different between urban and rural patients
(p-value = 0.026) educated and non-educated (p-value
< 0.001). There was no significance difference in first
place of contact with respect to gender and income.
Concerning reasons that made the patient choose the
first conventional health provider were, 56.6% patients
chose because the facility/provider was found nearer,
28.7% because of better and quality services they
assumed to get, 8.5% because of fair price charged for
services, 6.2% mentioned that because of good contact
and hospitality attracted them.
Up on first presentation to a health care provider,
34.9% of symptomatic patients were given non-anti-TB
drugs, while sputum for acid fast bacilli test was taken
for only 24.8% of the symptomatic patients, 20.9% re-
ferred to other health facility and only 19.4% started
anti-TB drug.
Respondents' general knowledge of TB and stigma
associated with TB
More than half of the study participants (65%) heard
about TB before. Small proportion of respondents (8.5%)
knew microbes cause TB disease. The majority (61.2%)
of the respondents had unsatisfactory (poor) knowledge
on TB, while 33.3% had average or fair knowledge and
the rest 5.4% were knowledgeable about TB.
Regarding the level of stigma associated with TB, 3.1%
told for nobody about their illness, most of them
informed family members and close confidants. The ma-
jority (70.0%) of the respondents experienced no stigma,
while 24.0% some stigma and the rest (6.0%) were highly
stigmatized because of TB.
Patient delay
The median delay from onset of symptoms to first visit
of a health provider was 63 days, range (14–896 days).
Patient delay has contributed 53% to the overall total
delay to treatment. However, only 11.6% of patients
were able to report within the first two weeks (accept-
able delay) after developing symptoms of pulmonary
TB whereas, for 89.9% of the respondents it took more
than 14 days. The longest delay was reported to be 2.5
years.
About 90% of patients, who delayed seeking health
care for more than 14 days, were asked for reasons
of their delay, 20.9% of patients delayed assuming
that symptom will disappear by itself, while 22.5%
delayed because of shortage of money for transporta-
tion and health care, 12.4% following traditional/
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cilities were too far. Some of them mentioned other
reasons, like workload (7.0%), money was not pro-
vided on time from family (4.7%), lack of transporta-
tion (7.0%), afraid of long processes in health
facilities (2.3%), and the rest (15.4%) provided no
specific reason.
In the logistic regression patients who lived beyond
10 kilometers radius of a health facility were 2.5 times
more likely to delay compared to those lived within 10
kilometers radius (AOR = 2.50, 95%CI 1.67–9.44).
Illiterate patients were 2.6 times more likely delay
compared to their counterparts (AOR = 2.65, 95%CI
1.72-9.73). Patients working some times before illness
were delay compared to those severely ill (bedridden)
(AOR = 15.1, 95%CI 2.84-80.37). Place of first visit
being traditional healer, drug shop, private clinic and
health post, were 12 times more likes delay compared
to those first visit health center and hospitals(place of







Place of first visit Traditional healer, Drug shops,
private clinic and health post





Family income (Birr) ≤ 100 per month
100 to 300 per month
300to 500 per month
>500 per month













Patient delay: ≥ 2 weeks, COR=Crude Odds Ration, AOR=Adjusted Odds Ratio, ¥ aHealth provider delay
The median health provider delay was 34 days (range 8–
105) days. The main reason for the diagnosis delay were,
advice or other drug was given rather than anti-TB treat-
ment, lack of reagent and delay of sputum examination
in laboratory, and long appointment time to return to
health facility. Concerning the place of TB diagnosis
55.8% was confirmed at hospital level, 44.2% were in
health centers that were closer to the community. After
confirmation of TB diagnosis, median treatment delay of
2 days was observed (mean = 2.1 days), the maximum
observed treatment delay was 11 days. Forty seven per-
cent of total delay was contributed by health provider
delay. The last diagnosing facility delay contributed
17.8% to the total health system delay, while days spent
after TB diagnosis (treatment delay), contributed 6.3% to
health system delay.
In the logistic regression patients who lived in rural
area were 2.9 times more likely delayed compared to
those who live in urban areas (AOR = 2.87, 95% CIary Tuberculosis patients in pastoralist community, Bale
Patient delay COR(95%CI) AOR¥ (95%CI)
Yes*(%) No (%)
52(92.9) 4(7.1) 2.3(0.69-7.67) 0.44(.11-1.78)
62(84.9) 11(15.1) 1.00 1.00
90(92.8) 7(7.2) 4.3(1.40-13.00) 5.1(1.39-18.90)
24(75) 8(25) 1.00 1.00
92(96.8) 3(3.2) 16.7(4.34-64.39) 12.2(2.80-53.11)
22(64.7) 12(35.3) 1.00 1.00
89(90.8) 9(9.2) 2.4(0.77-7.3) 1.4(0.31-5.87)
25(80.6) 6(19.4) 1.00 1. 00
88(92.6) 7(7.4) 3.9(1.28-11.60) 2.7(1.22-9.73)
26(81.3) 8(18.7) 1.00 1.00
11(84.6) 2(15.4) 1.2(.098-`14.69) 0.3(.02-9.42)
43(82.6) 9(17.4) .48(.094-2.41) 0.03(0.04-2.63)
39(92.8) 3(7.2) 1.3(0.20-8.42) 0.4(0.04-4.93)
20(90.9) 2(9.1) 1.00 1.00
85(92.4) 7(7.6) 3.4(1.12-10.05) 2.5(1.01-9.44)
29(73.4) 8(26.6) 1.00 1.00
65(83.3) 13(16.7) 1.00 1.00
49(96.1) 2(3.9) 4.9(1.06-22.74) 3.5(0.64-18.50)
20(95.2) 1(4.8) 3.4(0.67-66.82) 2.2(0.37-12.90)
65(98.5) 1(1.5) 11.4(2.37-54.39) 15.1(2.84-80.37)
31(73.8) 11(26.2) 1.00 1.00
67(91.8) 6(8.2) 8.4(1.78-19.5) 6.67(3.81-11.99)
49(89.1) 6(10.9) 1.00 1.00
djusted for variables in the table.
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more likely delay compared to those literate patients
(AOR = 3.47 95%CI 1.16-10.30). Patients with good
functional status were 2.2 times delayed compared to
those severely ill (bedridden) (AOR = 2.18, 95% CI
1.13-4.32). Patients who visit more than 2 different
types of health service providers before the start of
anti-TB treatment were 3.2 times more likely delayed
compared to those with 2 or less (AOR = 3.2, 95% CI
1.2-7.86). Patients who first visited drug shop, private
clinic and health post, were more likes delayed com-
pared to those who first visited health center and hos-
pitals (place of diagnosis) (OR = 19. 7; 95%CI 12.63-
34.52) (Table 3).
Total delay
The median total delay was 97 days. Only 3.1% of the
total respondents were detected and put on treatment











Family income (Birr) ≤ 100 per month
100 to 300 per month
300 to 500 per month
>500 per month
Distance from the facility >10KM
≤10KM
Level of severity before illness Working full time
Working some times
Bedridden
Tuberculosis patient contact Yes
No
*Types of different health service
provider contact till start of AntiTB treatment
≤ 2 types
> 2 types
Types of health facility first visited by patients Health Center/Govern
hospital
Health post /private c
/drug shop
* Doesn’t include repeated visits patients made to one health provider, ** Provider
adjusted for variables in the table.whereas for 96.1% of the respondents treatment was
started after twenty one days. The major proportion
(53%) of the total delay was attributed to patient delay.
The choice of first health care provider appeared to in-
fluence the median total delay to treatment Patients who
first visited government hospital reported the shortest
delay from first visit to treatment (median 35 days,
n = 26), while those who first visited traditional or spirit-
ual healer reported the longest delay (median 90 days,
n = 38). It was also, observed that people of higher edu-
cation started treatment early compared to patients of
lower educational status (p = 0.006).
Discussion
Early diagnosis of disease and prompt initiation of treat-
ment is essential for an effective TB control program.
Delay in diagnosis may worsen the disease, increase risk
of poor clinical outcome, including death and enhance
transmission of TB in the community [19,20]. In thisnary Tuberculosis patients in pastoralist community, Bale
Provider delay COR (95%CI) AOR ¥(95%CI)
Yes** (%) NO (%)
47(83.9) 9(6.1) 1.59(.65-3.88) 1.28(.40-4.06)
56(76.7) 17(23.3) 1.00 1. 00
83(85.6) 14(14.4) 3.74(1.49-9.38) 2.87(1.01-8.10)
19(61.3) 12(38.7) 1.00 1.00
77(78.6) 21(21.4) 0.71(0.24-2.06) 0.39(.09-1.74)
26(83.9) 5(16.1) 1.00 1.00
80(84.2) 15(15.8) 2.55(1.03-6.31) 3.47(1.16-10.30)
23(67.6) 11(32.4) 1.00 1.00
11(84.6) 2(15.4) 0.87(.13-6.03) .54(.04-7.47)
42(80.7) 10(19.3) . 66(.166-2.67) .46(.08-2.56)
31(73.8) 11(26.2) .45(.11-1.80) .47(.09-2.50)
19(86.4) 3(13.6) 1.00 1.00
77(83.7) 15(6.3) 2.17(.89-5.32) 1.41(0.42-4.71)
26(72.3) 11(27.7) 1.00 1.00
17(80.9) 4(9.1) 3.9(1.21-5.95) 2.18(1.13-4.32)
52(78.8) 14(21.2) 3.4(.22-7.76) 2.48 (.15-4.32)
22(52.4) 20(47.6) 1.00 1.00
29(93.5) 2(6.5) 4.7(1.04-21.18) 2.73(0.21-14.62)
74(75.5) 24(24.5) 1.00 1.00
22(53.7) 19(46.3) 1.00 1.00
76(86.4) 12(13.6) 5.4(1.54-9.21) 3.2(1.2-7.86)
ment 35(48.6) 37(51.4) 1.00 1.00
linic 53(94.6) 3(5.4) 18.7(12.46-28.84) 19. 7(12.63-34.52)
delay: ≥ 1 week. COR=Crude Odds Ration, AOR=Adjusted Odds Ratio, ¥
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patient and health provider delay were 63 and 34 days,
respectively. Ninety six percent of the patients were
delayed for more than three weeks recommended to de-
tect suspected TB. The delays are attributed to alterna-
tive treatment, health workers' low index of suspicion,
access to diagnosis and treatment and patient
characteristics.
The patient delay from onset of symptoms to first visit
of a health provider ranges from 14 to 896 days (median
of 63 days) which is much longer than the acceptable
duration of two weeks recommended by the WHO for
suspected TB cases [7]. The delay in our study is com-
parable with Somali region Ethiopia [14] (median, 60
days) and Addis Ababa (median, 60 days) [21]. However
it is much higher than, from Amhara region of Ethiopia
(median, 30 days) [12], Awasa, Ethiopia (median, 31
days) [13], and Tigray region (median, 30 days) [6]. In
addition the delay is much higher than that reported
from other African countries Cameron (median, 14 days)
[22], Zambia [23] and Gambia [24].
The difference observed with most studies could be
due to the difference in the population characteristics.
Our study focused on pastoralist communities similar to
the study conducted in Somali region of Ethiopia [14].
The population is characterized by mobility and
illiteracy; in this study 73.6% of patents are illiterate and
have poor accesses to health facilities. Access to health
care is defined in Ethiopia as living within 10 km radius
to health facility. In this study 71.4% of the patient live
out of 10 kilometers radius from health facility, hence
lacked access to health care. Previous study has docu-
mented that pastoralist communities are more margina-
lized than the settled rural residents [14].
Patient delay significantly varied with the patients’ area
of residence. Patients from rural had high median delay
compared to those from urban. In addition patients with
close proximity to health facility had lower delays.
Patients that initially visited non-formal health care pro-
viders had longer median patients' delay compared to
those who went directly to health provider. This was
similar to study done in northern part of Ethiopia [12].
All these factors add up to the importance of access to
health information and health facilities. In particular to
this study DOTS services which take into account the
unique life style of pastoralist community are important.
In addition understanding the migratory pattern of the
pastoralist community would give a better idea of where
to locate health facilities for such services. One critical
observation here could be considerable number of
patients seek treatment from non-formal health sector
and private health providers. Inclusion of the non-
formal health providers as referral allies and inclusion of
private sector in the TB-DOTS program can significantlyreduce both diagnosis and treatment delays. In Ethiopia
there are initiatives to foster public private partnership
for TB treatment in major towns; therefore expansion of
these services into the remote rural areas is a timely
agenda.
The major reasons mentioned by patients for delay in
treatment seeking were knowledge related, access and fi-
nancial problems. Similar findings were reported from
Nigeria [25]. This highlights the importance of decentra-
lized TB treatments services which address the chal-
lenges faced by the pastoralist community.
On the other hand, sex and level of knowledge about
disease and stigma attached to TB patients did show no
significant difference on time of presentation to health
care providers it differ from a study done in Nigeria
[25], other several studies showed stigma attached to the
TB patient as contextual factor associated to delayed
seeking of the health services [20,26] which is not the
case in our study.
The median provider delay from first presentation to
the health facility until start of Tb treatment was 34
days, (range 7–105). This was lower than report from
Ghana (median, 56 days) [27] but much higher than the
findings of studies in Addis Ababa [21], Ethiopia (me-
dian, 6 days), Somali, Ethiopia (median, 6 days) [14] and
Amhara region (median, 21 days) [12]. This difference
might be due to low index of suspicion to TB symptoms
by health providers the area is characterized by less
experienced health providers. Experienced health provi-
ders tend to migrate to urban settings and to areas
better-off in infrastructure. In addition supply shortage
for diagnosis of smear positive TB contributes to the
delays.
Most (55.8%) of TB diagnoses were confirmed at hos-
pital level than health centers or clinics that were closer
to the community, while only 9.3% of the patients visited
hospital at their first visits. Although, all of the health fa-
cilities included in this study were entitled to provide
the diagnostic and treatment services, the participation
of health centers was very limited in contributing to the
case detection. This is unacceptable when we look that
most of the patients (56.1%) were following the current
treatment in health centers after they were referred back
from hospitals. Similar situation was reported by another
study from Ethiopia [12] where most diagnosis of TB
was made in district hospitals.
The current study confirms that those who visited
more than two health facility had high provider delay.
This is in consistent with study conducted in Zambia,
where multiple health seeking encounters contributed to
the prolonged duration of health service delay along
with the associated medical costs [28]. In addition
patients who visited health facilities with no diagnostic
facilities were more delayed. In our study majority of
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examined correctly for TB or referred to diagnostic facil-
ities up on their first arrival, rather most (34.1%) of them
were given treatment for diseases other than TB. This
highlights the importance of establishing functional re-
ferral pathways between first encounter points and point
of diagnosis. In our context building the capacity of
health providers at first level health facilities and ensur-
ing supply chain management could contribute to the
reduction of delays in diagnosis and treatments.
Patients’ characteristics such as education and rural
residence were associated with the provider delays. All
this factors contribute to the biomedical knowledge of
patients on TB. Severity of the illness was also another
factor contributing to delays. This might indicate that
the pastoralist community seeks treatment for at an
advanced disease stage.
The current study has limitations: recall bias might be
there as patients were asked about events which hap-
pened sometimes back. However, we have included
patients which were on treatment for not more than two
weeks to reduce the recall bias.Conclusions
The study identified extreme patient and provider delays
among pastoralist communities in Southeast Ethiopia.
The factors associated with patient delay were rural resi-
dence, being illiterate, low access to health care facilities,
and first visit to non-formal or first level facilities and
private providers.
Factors associated with provider delay include rural
residence, being illiterate, health post /private clinic
/drug shop being first contact point and having visited
more than two health care providers. To increase case
detection establishing functional referral pathways,
building the capacity of health providers to increase the
index of suspicion and availing rapid diagnostic test for
TB at lowest health facilities are important first step. In-
clusion of non-formal health sectors and private provi-
ders in the process of case detection and identification
could contribute in reducing delays. To increase access
to DOTS program by pastoralist community it is im-
perative to establish treatment centers which takes into
consideration the lifestyle of the community and follows
migratory patterns. Finally improving awareness of the
community is very important to induce early treatment
seeking behavior among pastoralist communities.
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